APA (7th ed.) Citation

Kim, M. Y., Guerra, M. M., Kaplowitz, E., Laskin, C. A., Petri, M., Branch, D. W., . . . Salmon, J. E. (2018). Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Annals of the rheumatic diseases, 77(4), 549-555. https://doi.org/10.1136/annrheumdis-2017-212224

Chicago Style (17th ed.) Citation

Kim, Mimi Y., et al. "Complement Activation Predicts Adverse Pregnancy Outcome in Patients with Systemic Lupus Erythematosus And/or Antiphospholipid Antibodies." Annals of the Rheumatic Diseases 77, no. 4 (2018): 549-555. https://doi.org/10.1136/annrheumdis-2017-212224.

MLA (9th ed.) Citation

Kim, Mimi Y., et al. "Complement Activation Predicts Adverse Pregnancy Outcome in Patients with Systemic Lupus Erythematosus And/or Antiphospholipid Antibodies." Annals of the Rheumatic Diseases, vol. 77, no. 4, 2018, pp. 549-555, https://doi.org/10.1136/annrheumdis-2017-212224.